The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Mesenchymal Stem Cells (hMSC) Market Research Report 2025
Synopsis
Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types.
The global Human Mesenchymal Stem Cells (hMSC) market was valued at US$ 81 million in 2023 and is anticipated to reach US$ 140.1 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
North American market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Mesenchymal Stem Cells (hMSC) in Medical Application is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Mesenchymal Stem Cells (hMSC) include PromoCell, ThermoFisher, KURABO, Lifeline Cell Technology and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Mesenchymal Stem Cells (hMSC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Mesenchymal Stem Cells (hMSC).
Report Scope
The Human Mesenchymal Stem Cells (hMSC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Mesenchymal Stem Cells (hMSC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Mesenchymal Stem Cells (hMSC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PromoCell
ThermoFisher
KURABO
Lifeline Cell Technology
Merck
Segment by Type
Umbilical Cord Matrix hMSC
Bone Marrow hMSC
Adipose Tissue hMSC
Other
Segment by Application
Medical Application
Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Mesenchymal Stem Cells (hMSC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types.
The global Human Mesenchymal Stem Cells (hMSC) market was valued at US$ 81 million in 2023 and is anticipated to reach US$ 140.1 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
North American market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Mesenchymal Stem Cells (hMSC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Mesenchymal Stem Cells (hMSC) in Medical Application is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Mesenchymal Stem Cells (hMSC) include PromoCell, ThermoFisher, KURABO, Lifeline Cell Technology and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Mesenchymal Stem Cells (hMSC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Mesenchymal Stem Cells (hMSC).
Report Scope
The Human Mesenchymal Stem Cells (hMSC) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Mesenchymal Stem Cells (hMSC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Mesenchymal Stem Cells (hMSC) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PromoCell
ThermoFisher
KURABO
Lifeline Cell Technology
Merck
Segment by Type
Umbilical Cord Matrix hMSC
Bone Marrow hMSC
Adipose Tissue hMSC
Other
Segment by Application
Medical Application
Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Mesenchymal Stem Cells (hMSC) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Mesenchymal Stem Cells (hMSC) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Umbilical Cord Matrix hMSC
1.2.3 Bone Marrow hMSC
1.2.4 Adipose Tissue hMSC
1.2.5 Other
1.3 Market by Application
1.3.1 Global Human Mesenchymal Stem Cells (hMSC) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Application
1.3.3 Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Mesenchymal Stem Cells (hMSC) Market Perspective (2019-2030)
2.2 Human Mesenchymal Stem Cells (hMSC) Growth Trends by Region
2.2.1 Global Human Mesenchymal Stem Cells (hMSC) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Mesenchymal Stem Cells (hMSC) Historic Market Size by Region (2019-2024)
2.2.3 Human Mesenchymal Stem Cells (hMSC) Forecasted Market Size by Region (2025-2030)
2.3 Human Mesenchymal Stem Cells (hMSC) Market Dynamics
2.3.1 Human Mesenchymal Stem Cells (hMSC) Industry Trends
2.3.2 Human Mesenchymal Stem Cells (hMSC) Market Drivers
2.3.3 Human Mesenchymal Stem Cells (hMSC) Market Challenges
2.3.4 Human Mesenchymal Stem Cells (hMSC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Mesenchymal Stem Cells (hMSC) Players by Revenue
3.1.1 Global Top Human Mesenchymal Stem Cells (hMSC) Players by Revenue (2019-2024)
3.1.2 Global Human Mesenchymal Stem Cells (hMSC) Revenue Market Share by Players (2019-2024)
3.2 Global Human Mesenchymal Stem Cells (hMSC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Mesenchymal Stem Cells (hMSC) Revenue
3.4 Global Human Mesenchymal Stem Cells (hMSC) Market Concentration Ratio
3.4.1 Global Human Mesenchymal Stem Cells (hMSC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Mesenchymal Stem Cells (hMSC) Revenue in 2023
3.5 Human Mesenchymal Stem Cells (hMSC) Key Players Head office and Area Served
3.6 Key Players Human Mesenchymal Stem Cells (hMSC) Product Solution and Service
3.7 Date of Enter into Human Mesenchymal Stem Cells (hMSC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Mesenchymal Stem Cells (hMSC) Breakdown Data by Type
4.1 Global Human Mesenchymal Stem Cells (hMSC) Historic Market Size by Type (2019-2024)
4.2 Global Human Mesenchymal Stem Cells (hMSC) Forecasted Market Size by Type (2025-2030)
5 Human Mesenchymal Stem Cells (hMSC) Breakdown Data by Application
5.1 Global Human Mesenchymal Stem Cells (hMSC) Historic Market Size by Application (2019-2024)
5.2 Global Human Mesenchymal Stem Cells (hMSC) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Mesenchymal Stem Cells (hMSC) Market Size (2019-2030)
6.2 North America Human Mesenchymal Stem Cells (hMSC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2019-2024)
6.4 North America Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Mesenchymal Stem Cells (hMSC) Market Size (2019-2030)
7.2 Europe Human Mesenchymal Stem Cells (hMSC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2019-2024)
7.4 Europe Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Size (2019-2030)
8.2 Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Mesenchymal Stem Cells (hMSC) Market Size (2019-2030)
9.2 Latin America Human Mesenchymal Stem Cells (hMSC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2019-2024)
9.4 Latin America Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Mesenchymal Stem Cells (hMSC) Market Size (2019-2030)
10.2 Middle East & Africa Human Mesenchymal Stem Cells (hMSC) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Mesenchymal Stem Cells (hMSC) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PromoCell
11.1.1 PromoCell Company Detail
11.1.2 PromoCell Business Overview
11.1.3 PromoCell Human Mesenchymal Stem Cells (hMSC) Introduction
11.1.4 PromoCell Revenue in Human Mesenchymal Stem Cells (hMSC) Business (2019-2024)
11.1.5 PromoCell Recent Development
11.2 ThermoFisher
11.2.1 ThermoFisher Company Detail
11.2.2 ThermoFisher Business Overview
11.2.3 ThermoFisher Human Mesenchymal Stem Cells (hMSC) Introduction
11.2.4 ThermoFisher Revenue in Human Mesenchymal Stem Cells (hMSC) Business (2019-2024)
11.2.5 ThermoFisher Recent Development
11.3 KURABO
11.3.1 KURABO Company Detail
11.3.2 KURABO Business Overview
11.3.3 KURABO Human Mesenchymal Stem Cells (hMSC) Introduction
11.3.4 KURABO Revenue in Human Mesenchymal Stem Cells (hMSC) Business (2019-2024)
11.3.5 KURABO Recent Development
11.4 Lifeline Cell Technology
11.4.1 Lifeline Cell Technology Company Detail
11.4.2 Lifeline Cell Technology Business Overview
11.4.3 Lifeline Cell Technology Human Mesenchymal Stem Cells (hMSC) Introduction
11.4.4 Lifeline Cell Technology Revenue in Human Mesenchymal Stem Cells (hMSC) Business (2019-2024)
11.4.5 Lifeline Cell Technology Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Human Mesenchymal Stem Cells (hMSC) Introduction
11.5.4 Merck Revenue in Human Mesenchymal Stem Cells (hMSC) Business (2019-2024)
11.5.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
